Atypical hemolytic uremic syndrome (aHUS) patients suffer from lifelong risk of recurrence. The COMMUTE trial program is actively enrolling treatment naive adult, adolescent and pediatric patients with aHUS for Phase III, multicenter, single-arm studies evaluating a subcutaneous antibody treatment in patients with aHUS. #ahus #esrd #clinicaltrials https://lnkd.in/giE9jZHW
About us
The official Genentech Medical LinkedIn page for sharing the latest scientific, medical, and clinical trial information with US healthcare professionals. • By interacting with this LinkedIn page, you confirm that you are a US healthcare professional. • There are regulations that govern our LinkedIn page. We reserve the right to engage with posts that follow our community guidelines (https://bit.ly/4aqwv2h). Not all posts will receive responses. Responses will be provided during business hours M-F, 5am to 5pm PT. • This page provides a platform for Genentech Medical Affairs to share scientific information, disease education, and clinical trial updates. We welcome your comments. Please stay on topic and refrain from using inappropriate language. • If you are aware of anyone that has experienced any adverse events related to a Genentech product, report them immediately to Genentech Drug Safety by emailing [email protected] or calling 1-888-835-2555. You can also contact the FDA directly by visiting www.fda.gov/medwatch or calling 1-800-FDA-1088. We will report this adverse event to the FDA and may contact you with questions or request additional information. • Respect others’ privacy and do not share personal information that is not in the public domain. • Do not reference Genentech products and services or alternative therapeutic options or your posts may be deleted. • This page is for informational purposes only and is not a forum to solicit or give medical advice. • The sharing of content or links to third-party sites is not an indication of endorsement by Genentech and Genentech is not responsible for this content. • If you have a medical inquiry, contact our Medical Information team M-F, 5am to 5pm PT by calling 1-800-821-8590.
- Website
-
https://www.genentech-medinfo.com/
External link for Genentech Medical
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
Updates
-
Atypical hemolytic uremic syndrome (aHUS) is associated with high mortality. The COMMUTE trial program is now enrolling for Phase III, multicenter, single-arm studies evaluating a subcutaneous antibody treatment in adult, adolescent and pediatric patients with treatment naive aHUS. #ahus #esrd #clinicaltrials https://lnkd.in/gpBdcYRM
-
TAKE PART: The WeSMA clinical trial is actively enrolling patients near you, with 100% remote participation available. Patients with a confirmed diagnosis of 5q-autosomal recessive SMA and currently prescribed an oral SMA medication are encouraged to participate. The WeSMA study will help to understand the safety and effectiveness of long-term prescribed use of an oral survival of motor neuron 2 (SMN2) pre-mRNA splicing modifier, and will help others with SMA by contributing to clinical research. #SMA #neurology #clinicaltrials https://lnkd.in/gtNv69tQ
-
Do you have any pediatric or adult patients with Spinal Muscular Atrophy (SMA) and currently being treated with an oral SMA medication? The WeSMA clinical trial is actively enrolling patients to understand the safety and effectiveness of long-term prescribed use of an oral survival of motor neuron 2 (SMN2) pre-mRNA splicing modifier, and will help others with SMA by contributing to clinical research. #SMA #neurology #clinicaltrials https://lnkd.in/gb3WUe9v
-
The Kirros study is actively enrolling patients with unresectable, locally advanced or metastatic hepatocellular carcinoma (HCC) with Child-Pugh B7 or B8 cirrhosis. The study will be evaluating the safety and efficacy of first-line treatment options. Trial locations are available nationwide. Consider referring your eligible patients. #LiverCancer #HepatocellularCarcinoma #HCCresearch https://lnkd.in/gkSERBX5
-
Patients with hepatocellular carcinoma (HCC) and moderately impaired liver function are often excluded from systemic therapy clinical trials. The Kirros study, developed specifically for HCC patients with Child-Pugh B7 or B8 cirrhosis, is actively enrolling patients with unresectable, locally advanced or metastatic HCC. The study will be evaluating the safety and efficacy of first-line treatment options. Consider referring your eligible patients. #LiverCancer #HepatocellularCarcinoma #HCCresearch https://lnkd.in/gPuACrRW
-
Missed us at #ASRS2024? View our #ophthalmology research by visiting MEDICALLY, our online platform for scientific exchange, congress information, and resources. https://lnkd.in/gPN8ihab
-
-
Do you have patients with food allergies in your practice? In this rapidly moving medical and scientific landscape, Genentech Medical invites you, as healthcare providers, to stay current with our #FoodAllergy-focused data releases, clinical trial study design and indication resources: 𝐃𝐚𝐭𝐚 𝐑𝐞𝐥𝐞𝐚𝐬𝐞𝐬 View the latest Genentech publications and congress data releases: https://lnkd.in/giCKm4Mt 𝐆𝐞𝐧𝐞𝐧𝐭𝐞𝐜𝐡 𝐁𝐢𝐨𝐥𝐨𝐠𝐢𝐜 𝐓𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐟𝐨𝐫 𝐅𝐨𝐨𝐝 𝐀𝐥𝐥𝐞𝐫𝐠𝐲 Clinical trial study design and indications for your patients: https://lnkd.in/gEfX_d32 For more information, connect with your local MSL here: https://lnkd.in/ga-r7J_K, or contact Genentech Medical Information here: https://lnkd.in/gjcu3XC5 #Immunology #MedicalResources
-
The lives of 1 in 13 US children are significantly affected by #FoodAllergies. Check out our Genentech Medical website where you can learn more and find up-to-date medical resources about #FoodAllergy: 𝐅𝐨𝐨𝐝 𝐀𝐥𝐥𝐞𝐫𝐠𝐲 𝐃𝐢𝐬𝐞𝐚𝐬𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 Understand the burden and recognize the symptoms of the disease for your patients via short videos and infographics: https://lnkd.in/gnP7ZCpm 𝐌𝐞𝐝𝐢𝐜𝐚𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐑𝐞𝐬𝐨𝐮𝐫𝐜𝐞𝐬 Search our online medical library for responses to your food allergy-related questions: https://lnkd.in/g-Px8SyZ 𝐋𝐨𝐨𝐤𝐢𝐧𝐠 𝐟𝐨𝐫 𝐦𝐨𝐫𝐞 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧? Your local Medical Science Liaison (MSL) can be found here: https://lnkd.in/gq-u6wSH, or you can contact Genentech Medical Information here: https://lnkd.in/gqFHbg3r #Immunology #MedicalResources
-
Genentech is presenting at #ASRS24, showcasing the latest advancements in #ophthalmology research and treatment. Join us in our commitment to advancing science and improving patient outcomes at our latest sessions. https://lnkd.in/emA4Eur